<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2984705R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2786</journal-id>
<journal-id journal-id-type="nlm-ta">Cancer Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Cancer Res.</journal-id>
<journal-title-group>
<journal-title>Cancer research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0008-5472</issn>
<issn pub-type="epub">1538-7445</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27923837</article-id>
<article-id pub-id-type="pmc">5290136</article-id>
<article-id pub-id-type="doi">10.1158/0008-5472.CAN-16-0655</article-id>
<article-id pub-id-type="manuscript">NIHMS835681</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The NCI-60 Methylome and its Integration into CellMiner</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Reinhold</surname>
<given-names>William C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Varma</surname>
<given-names>Sudhir</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sunshine</surname>
<given-names>Margot</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rajapakse</surname>
<given-names>Vinodh</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luna</surname>
<given-names>Augustin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kohn</surname>
<given-names>Kurt W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stevenson</surname>
<given-names>Holly</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yonghong</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heyn</surname>
<given-names>Holger</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nogales</surname>
<given-names>Vanesa</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moran</surname>
<given-names>Sebastian</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goldstein</surname>
<given-names>David J.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Doroshow</surname>
<given-names>James H.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meltzer</surname>
<given-names>Paul S.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Esteller</surname>
<given-names>Manel</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pommier</surname>
<given-names>Yves</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Developmental Therapeutics Branch, CCR, NCI, NIH, Bethesda, MD 20892</aff>
<aff id="A2"><label>2</label>Systems Research and Applications Corp., Fairfax, VA 22033</aff>
<aff id="A3"><label>3</label>HiThru Analytics LLC, Laurel, MD 20707</aff>
<aff id="A4"><label>4</label>Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02115, and Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="A5"><label>5</label>Genetics Branch, Developmental Therapeutic Program, CCR, NCI, NIH, Bethesda, MD 20892</aff>
<aff id="A6"><label>6</label>Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain</aff>
<aff id="A7"><label>7</label>Office of the Director, CCR, NCI, NIH, Bethesda, MD 20892</aff>
<aff id="A8"><label>8</label>Genetics Branch, CCR, NCI, NIH, Bethesda, MD 20892; Divison of Cancer Treatment and Diagnosis, CCR, NCI, NIH, Bethesda, MD 20892</aff>
<aff id="A9"><label>9</label>Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain</aff>
<aff id="A10"><label>10</label>Institucio Catalana de Recerca i Estudis Avan√ßats (ICREA), Barcelona, Catalonia, Spain</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Corresponding authors: William C. Reinhold, <email>wcr@mail.nih.gov</email>, Yves Pommier, <email>pommier@nih.gov</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2018</year>
</pub-date>
<volume>77</volume>
<issue>3</issue>
<fpage>601</fpage>
<lpage>612</lpage>
<!--elocation-id from pubmed: 10.1158/0008-5472.CAN-16-0655-->
<abstract>
<p id="P1">A unique resource for systems pharmacology and genomic studies is the NCI-60 cancer cell line panel, which provides data for the largest publicly available library of compounds with cytotoxic activity (~21,000 compounds), including 108 FDA-approved and 70 clinical trial drugs as well as genomic data, including whole-exome sequencing, gene and microRNA transcripts, DNA copy number, and protein levels. Here we provide the first readily usable genome-wide DNA methylation database for the NCI-60, including 485,577 probes from the Infinium HumanMethylation450k BeadChip array, which yielded DNA methylation signatures for 17,559 genes integrated into our open access CellMiner version 2.0 (<ext-link ext-link-type="uri" xlink:href="https://discover.nci.nih.gov/cellminer">https://discover.nci.nih.gov/cellminer</ext-link>). Among new insights, transcript versus DNA methylation correlations revealed the epithelial/mesenchymal gene functional category as being influenced most heavily by methylation. DNA methylation and copy number integration with transcript levels yielded an assessment of their relative influence for 15,798 genes, including tumor suppressor, mitochondrial, and mismatch repair genes. Four forms of molecular data were combined, providing rationale for microsatellite instability for 8 out of the 9 cell lines in which it occurred. Individual cell line analyses showed global methylome patterns with overall methylation levels ranging from 17 to 84%. A six-gene model including PARP1, EP300, KDM5C, SMARCB1 and UHRF1 matched this pattern. Additionally, promoter methylation of two translationally relevant genes Schlafen 11 (SLFN11) and methylguanine methyltransferase (MGMT) served as indicators of therapeutic resistance or susceptibility, respectively. Overall, our database provides a resource of pharmacological data that can reinforce known therapeutic strategies and identify novel drugs and drug targets across multiple cancer types.</p>
</abstract>
<kwd-group>
<kwd>mutations</kwd>
<kwd>CpGs</kwd>
<kwd>epigenetics</kwd>
<kwd>transcriptional regulation</kwd>
<kwd>precision medicine</kwd>
<kwd>pharmacogenomics</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>